Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
Takano M, Sugiyama T, Yaegashi N, Sakuma M, Suzuki M, Saga Y, Kuzuya K, Kigawa J, Shimada M, Tsuda H, Moriya T, Yoshizaki A, Kita T, Kikuchi Y. Takano M, et al. Among authors: shimada m. Int J Gynecol Cancer. 2008 Sep-Oct;18(5):937-42. doi: 10.1111/j.1525-1438.2007.01158.x. Epub 2007 Dec 13. Int J Gynecol Cancer. 2008. PMID: 18081792
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.
Takano T, Otsuki T, Tokunaga H, Toyoshima M, Utsunomiya H, Nagase S, Niikura H, Ito K, Yaegashi N, Yamada H, Tase T, Kagabu M, Shoji T, Sugiyama T, Sato N, Fujimoto T, Terada Y, Nakahara K, Kurachi H, Yokoyama Y, Mizunuma H, Soeda S, Nishiyama H, Matsumoto T, Sato S, Shimada M, Kigawa J. Takano T, et al. Among authors: shimada m. Int J Clin Oncol. 2014 Dec;19(6):1052-8. doi: 10.1007/s10147-013-0658-y. Epub 2014 Jan 7. Int J Clin Oncol. 2014. PMID: 24395448 Clinical Trial.
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit.
Otsuki A, Watanabe Y, Nomura H, Futagami M, Yokoyama Y, Shibata K, Kamoi S, Arakawa A, Nishiyama H, Katsuta T, Kudaka W, Shimada M, Sato N, Kotera K, Katabuchi H, Yaegashi N. Otsuki A, et al. Among authors: shimada m. Int J Gynecol Cancer. 2015 Jan;25(1):92-7. doi: 10.1097/IGC.0000000000000302. Int J Gynecol Cancer. 2015. PMID: 25347097 Clinical Trial.
Primary osteosarcoma of the uterine cervix: A case report.
Tsuji K, Watanabe Y, Tokunaga H, Shimada M, Watanabe M, Yaegashi N. Tsuji K, et al. Among authors: shimada m. J Obstet Gynaecol Res. 2017 Nov;43(11):1781-1783. doi: 10.1111/jog.13443. Epub 2017 Aug 17. J Obstet Gynaecol Res. 2017. PMID: 28815813
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan.
Matsumoto H, Shimokawa M, Nasu K, Shikama A, Shiozaki T, Futagami M, Kai K, Nagano H, Mori T, Yano M, Sugino N, Fujimoto E, Yoshioka N, Nakagawa S, Shimada M, Tokunaga H, Yamada Y, Tsuruta T, Tasaki K, Nishikawa R, Kuji S, Motohashi T, Ito K, Yamada T, Teramoto N. Matsumoto H, et al. Among authors: shimada m. J Gynecol Oncol. 2019 Nov;30(6):e103. doi: 10.3802/jgo.2019.30.e103. J Gynecol Oncol. 2019. PMID: 31576694 Free PMC article.
3,217 results